Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+129.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
12.1x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $125.10M | +52.2% |
| 2024 | $82.22M | +128.0% |
| 2023 | $36.07M | +248.4% |
| 2022 | $10.35M | - |